Macleods Pharms' Generic Nevirapine Receives Approval in US
Cipla recalls 4,800 bottles of anti-HIV tablets from US
Enforcement Report - Week of December 26, 2018
Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with GMP
Macleods Pharm’s Generic Nevirapine Approval In US
Aurobindo Pharma USA Generic Nevirapine Receives Approval In US
Aurobindo's Generic Nevirapine Receives Approval In US
On February 5, 2016, the World Health Organization (WHO) made available the Public Inspection Report (PIR) for Strides Shasun Ltd’s (Strides) Formulation II facility in Puducherry, India. According to the PIR, the inspection focused on Good Manufacturing Practices (GMPs) and resulted in the company remaining in continued compliance for the next three (3) years pending any additional inspections during this time period. This facility was acquired by Strides through its acquisition of Shasun Pharmaceuticals Limited (Shasun) after the company sold certain sterile facilities to Mylan.
Mylan`s Generic Nevirapine approved in US for HIV-1 infection and AIDS
Alvogen`s Generic Nevirapine approved in US for HIV-1 infection and AIDS